Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Standard 12-lead electrocardiography measures predictive of increased appropriate therapy in implantable cardioverter defibrillator recipients.

Shi B, Harding SA, Jimenez A, Larsen PD.

Europace. 2013 Jun;15(6):892-8. doi: 10.1093/europace/eus360. Epub 2012 Nov 1.

PMID:
23118007
2.

QRS fragmentation and the risk of sudden cardiac death in MADIT II.

Brenyo A, Pietrasik G, Barsheshet A, Huang DT, Polonsky B, McNitt S, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2012 Dec;23(12):1343-8. doi: 10.1111/j.1540-8167.2012.02390.x. Epub 2012 Jul 16.

PMID:
22805297
3.
4.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

5.

The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators.

Bhavnani SP, Kumar A, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J.

Europace. 2014 Jan;16(1):47-54. doi: 10.1093/europace/eut211. Epub 2013 Aug 16.

PMID:
23954920
6.

Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy.

Femenía F, Arce M, Van Grieken J, Trucco E, Mont L, Abello M, Merino JL, Rivero-Ayerza M, Gorenek B, Rodriguez C, Hopman WM, Baranchuk A; Fragmented QRS in Hypertrophic Obstructive Cardiomyopathy (FHOCM) Study Investigators.

J Interv Card Electrophysiol. 2013 Dec;38(3):159-65. doi: 10.1007/s10840-013-9829-z. Epub 2013 Sep 8.

PMID:
24013705
7.

Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle.

Borleffs CJ, Scherptong RW, Man SC, van Welsenes GH, Bax JJ, van Erven L, Swenne CA, Schalij MJ.

Circ Arrhythm Electrophysiol. 2009 Oct;2(5):548-54. doi: 10.1161/CIRCEP.109.859108. Epub 2009 Aug 5.

8.

Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.

Forleo GB, Della Rocca DG, Papavasileiou LP, Panattoni G, Sergi D, Duro L, Mahfouz K, Magliano G, Santini L, Romeo F.

J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):779-84. doi: 10.2459/JCM.0b013e32834ae458.

PMID:
21941203
9.

Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr.

Circulation. 2004 Oct 5;110(14):1885-9. Epub 2004 Sep 27.

10.

Fragmented QRS predicts the arrhythmic events in patients with heart failure undergoing ICD implantation for primary prophylaxis: more fragments more appropriate ICD shocks.

Ozcan F, Turak O, Canpolat U, Avci S, Tok D, Isleyen A, Cebeci M, Yuzgeçer H, Gurel OM, Topaloglu S, Aras D, Basar FN, Aydogdu S.

Ann Noninvasive Electrocardiol. 2014 Jul;19(4):351-7. doi: 10.1111/anec.12141. Epub 2014 Feb 17.

PMID:
24920012
11.

Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients.

Saba S, Marek J, Alam MB, Adelstein E, Schwartzman D, Jain S, Gorcsan J.

J Interv Card Electrophysiol. 2014 Dec;41(3):211-5. doi: 10.1007/s10840-014-9953-4. Epub 2014 Nov 13.

PMID:
25391355
12.

Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole.

Safak E, Schmitz D, Konorza T, Wende C, De Ros JO, Schirdewan A; Linox DX Study Investigators.

Pacing Clin Electrophysiol. 2013 Aug;36(8):952-62. doi: 10.1111/pace.12171. Epub 2013 May 21.

PMID:
23692262
14.

How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?

Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ.

Europace. 2014 Jul;16(7):1015-21. doi: 10.1093/europace/eut370. Epub 2013 Dec 18.

PMID:
24351884
15.

Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.

Stockburger M, Celebi O, Krebs A, Knaus T, Nitardy A, Habedank D, Dietz R.

Europace. 2009 Jul;11(7):924-30. doi: 10.1093/europace/eup118. Epub 2009 May 15.

PMID:
19447808
16.

Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.

Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M.

Europace. 2012 Feb;14(2):224-9. doi: 10.1093/europace/eur307. Epub 2011 Sep 22.

PMID:
21946820
17.

Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.

Sredniawa B, Kowalczyk J, Lenarczyk R, Kowalski O, Sędkowska A, Cebula S, Musialik-Łydka A, Kalarus Z.

Kardiol Pol. 2012;70(5):447-55.

18.

Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.

Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.

Europace. 2009 Jan;11(1):80-5. doi: 10.1093/europace/eun288. Epub 2008 Oct 24.

PMID:
18952828
19.

Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.

Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.

Am J Cardiol. 2007 Aug 15;100(4):598-604. Epub 2007 Jun 28.

PMID:
17697813
20.

Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.

Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I.

J Am Coll Cardiol. 2012 Jun 5;59(23):2075-9. doi: 10.1016/j.jacc.2012.02.036.

Supplemental Content

Support Center